Δ-11-Tetrahydrocannabinol
1Provenance card
the boundary, as counts
Sources
175 with DOI
1 strong · 15 moderate · 1 weak
Compilations
12026-05-11T12:16:18.815Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
19last ruled 2026-06-04
0 awaiting a ruling
Issued documents
52026-10-19T20:31:19.158Z
notice · info card · emergency
Searches
191 with no results
queries and counts on the build
Claims checked
1204 supported
4 supported · 116 not
Correspondence
0received
consent field ships in Phase 4
Edges
312
derivations recorded for this entity
Complete over 17 sources, 1 compilation, and 19 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/delta-11-thc/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued emergency
- 2026-10-19issueIssued info_card
- 2026-10-02srcHexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review
- 2026-10-02srcSimilarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors
- 2026-10-02srcSynthesis of (-)-Δ9(11)-trans-tetrahydrocannabinol
- 2026-10-02srcDetermination of Cross-Reactivity of Contemporary Cannabinoids with THC Direct Immunoassay (ELISA) in Whole Blood.
- 2026-10-02srcPotency Analysis of Semi-Synthetic Cannabinoids in Vaping Oils Using Liquid Chromatography Diode Array Detector with Electrospray Ionization Time-of-Flight Mass Spectrometry for Confirmation of Analyte Identity.
- 2026-10-02srcEvaluation of ether and free hydroxyl analogs of delta-8, delta-9, 11-THC as cannabinoid antagonists.
- 2026-10-02srcElectron impact-induced fragmentation of the trimethylsilyl derivatives of monohydroxy-hexahydrocannabinols.
- 2026-10-02srcSynthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol.
- 2026-10-02srcIn vitro metabolism of delta-11-tetrahydrocannabinol in the mouse, rat, guinea pig, rabbit, hamster, gerbil and cat.
- 2026-10-02srcThe conformational analysis of delta 9- and delta 9,11-tetrahydrocannabinols in solution using high resolution nuclear magnetic resonance spectroscopy.
- 2026-10-02srcThe importance of the orientation of the C9 substituent to cannabinoid activity
- 2026-10-02srcStudies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol.
- 2026-10-02srcCardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine.
- 2026-10-02srcThe synthesis of (-)-delta-9(11)-trans-tetrahydrocannabinol.
- 2026-10-02srcDiscriminative stimulus effects of delta 9-tetrahydrocannabinol and delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys.
- 2026-10-02srcImportance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis of O,2-propano-delta 8-THC analogs
- 2026-10-02srcDelta(9-11)-Tetrahydrocannabinol | CID 167577
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal15 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-05-11proposalduration · inhaled · totalworking →
- 2026-05-11proposalduration · oral · totalworking →
- 2026-05-11revisionRevision 1
- 2026-05-11absenceSearched ClinicalTrials.gov for "delta-11-tetrahydrocannabinol" — no results
- 2026-05-11genGeneration — pipeline-v5 · with 1 morepipeline-v5
- 2026-05-11rungeneration run
The same entries, as forms: six forms.